ISSN: 0149-2918

Clinical Therapeutics Q2 Unclaimed

Elsevier Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

NA

Clinical Therapeutics focuses its scope in these topics and keywords: chinese, healthy, pharmacokinetics, review, treatment, patients, randomized, coronary, parallel, suspension, ...

Type: Journal

Type of Copyright: NA

Languages: English

Open Access Policy: NA

Type of publications: NA

Publication frecuency: NA

Categories: Pharmacology (Q2) Pharmacology (medical) (Q2) Pharmacology (medical) (Q2)

Price

NA €

Gold OA

-

Green OA

NA €

Non OA

Metrics

0,981

SJR Impact factor

134

H Index

223

Total Docs (Last Year)

672

Total Docs (3 years)

9030

Total Refs

1766

Total Cites (3 years)

587

Citable Docs (3 years)

2,33

Cites/Doc (2 years)

40,49

Ref/Doc

Other journals with similar parameters

Topics in antiviral medicine Q2
Pharmacoepidemiology and Drug Safety Q2
Pharmacogenomics Journal Q2
Pharmacogenomics and Personalized Medicine Q2
Skin Pharmacology and Physiology Q2

Aims and Scope

Best articles

A cost-of-illness study of lyme disease in the United States

A disease management case study in infectious disease

A disease management case study on asthma

A long-term comparative trial of cerivastatin sodium, a new HMG-CoA reductase inhibitor, in patients with primary hypercholesterolemia

A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients

A randomized, double-masked, clinical study of the efficacy of four nonsteroidal anti-inflammatory drugs in pain control after excimer laser photorefractive keratectomy

A randomized, open-label comparison of venlafaxine and fluoxetine in depressed outpatients

Amlodipine, felodipine, and isradipine in the treatment of chinese patients with mild-to-moderate hypertension

An estradiol matrix transdermal system for the prevention of postmenopausal bone loss

An immunophilin-binding assay for sirolimus

An outpatient prescription-medication benefit in medicare: So much time, so little consensus

Assessing the input costs of disease management programs

SHOW MORE ARTICLES

Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe

Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension

Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients

Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone

Cerivastatin versus branded pravastatin in the treatment of primary hypercholesterolemia in primary care practice in Canada: A one-year, open-label, randomized, comparative study of efficacy, safety, and cost-effectiveness

Clinical efficacy of dirithromycin in patients with bacteremic pneumonia

Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of postoperative obstetric or gynecologic pain

Combined metformin and insulin therapy for patients with type 2 diabetes mellitus

Comparative bioavailability of ceftibuten in capsule and suspension forms

Comparative study of the analgesic efficacy of flurbiprofen and diclofenac in patients following excimer laser photorefractive keratectomy

Compliance of pediatric patients with treatment involving antibiotic suspensions: A pilot study

Disease management contracting: legal issues

Comments

No comments ... Be the first to comment!

Publication speed

Review quality

Edition and editorial team

Paper Link

Attach one of your papers. We need to confirm that you have had a relation with this journal in order to review its service.